Cambrian Capital Partners logo

Cambrian Capital Partners

North America, Alberta, Canada, Edmonton

Description

Cambrian Capital Partners is a firm focused on providing off-market and creative investment solutions.

Investor Profile

Cambrian Capital Partners has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Life Science.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cambrian Capital Partners frequently co-invest with?

LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
HonorHealth
North America, Arizona, United States, Scottsdale
Co-Investments: 2
Top Corner Capital
North America, California, United States, Burlingame
Co-Investments: 1
TV
North America, New York, United States, New York
Co-Investments: 1
BlueStone Venture Partners
North America, Arizona, United States, Tucson
Co-Investments: 1

Which angels does Cambrian Capital Partners often collaborate with?

PH
North America, United States
Shared Deals: 1

What are some of recent deals done by Cambrian Capital Partners?

Journey Live

New York, New York, United States

Journey Live offers a preventative mental health solution to reduce turnover, tackle burnout, and help employees live healthier lives.

FitnessHealth CareMental HealthWellness
Series AJul 25, 2025
Amount Raised: $8,000,000
CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.

BiotechnologyHealth DiagnosticsLife ScienceMedical
Series AMay 1, 2025
Amount Raised: $13,500,000
CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences develops an evidence-based tool to help confirm a diagnosis of synucleinopathy.

BiotechnologyHealth DiagnosticsLife Science
SeedFeb 1, 2022
Amount Raised: $5,000,000

Find More Investors Like Cambrian Capital Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Cambrian Capital Partners | Pipeseed